Singapore vs Trinidad and Tobago: Reported number of people receiving antiretroviral therapy
Singapore
6,905
in 2024
Trinidad and Tobago
7,442
in 2025
Singapore rank
99th
Trinidad and Tobago rank
96th
Reported number of people receiving antiretroviral therapy over time
- Singapore
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 7,442 against 6,905 in Singapore, a difference of 537.
That makes Trinidad and Tobago's figure about 1.1 times Singapore's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Singapore ahead.
Singapore ranks 99th and Trinidad and Tobago ranks 96th of 143 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 517.1 | 1,442 | 924.7 | Trinidad and Tobago |
| 2010s | 4,181 | 6,288 | 2,107 | Trinidad and Tobago |
| 2020s | 6,606 | 7,193 | 586.4 | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported number of people receiving antiretroviral therapy, Singapore or Trinidad and Tobago?
- Trinidad and Tobago, at 7,442 against 6,905 in Singapore as of 2025.
- What is the difference in reported number of people receiving antiretroviral therapy between Singapore and Trinidad and Tobago?
- 537, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Singapore and Trinidad and Tobago?
- 25 years are reported by both, from 2000 to 2024.
- How do Singapore and Trinidad and Tobago rank globally for reported number of people receiving antiretroviral therapy?
- Singapore ranks 99th and Trinidad and Tobago ranks 96th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Reported number of people receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.